Otto Ettala

Feasibility and repeatability of DWI-derived diffusion heterogeneity for discriminating clinically significant prostate cancer (2027)

Magnetic Resonance Imaging

Chu, Rui Jian; Jambor, Ivan; Ettala, Otto; Taimen, Pekka; Pesola, Marko; Saunavaara, Jani; Aronen, Hannu; Boström, Peter J.; Merisaari, Harri

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Effect of neoadjuvant androgen deprivation therapy on prostate and tumor morphology prior to MRI-guided transurethral ultrasound ablation of prostate cancer (2026)

International Journal of Hyperthermia

Virtanen, Ilari; Mäkelä, Pietari; Sainio, Teija; Högerman, Mikael; Nurminen, Pertti; Ettala, Otto; Anttinen, Mikael

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Comparison of [18F]DCFPyL and [18F]FAPI-74 PET/CT imaging in metastatic prostate cancer (2026)

European Journal of Nuclear Medicine and Molecular Imaging

Hyväkkä, Anniina; Seppänen, Marko; Sundvall, Maria; Sivonen, Veera; Mattila, Kalle; Anttinen, Mikael; Ettala, Otto; Högerman, Mikael; Kirjavainen, Anna; Eskola, Olli; Forsback, Sarita; Saunavaara, Virva; Arvola, Samuli; Kilpinen, Kusti; Taimen, Pekka; Malaspina, Simona; Minn, Heikki

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Impact of asymptomatic bacteriuria on the outcomes and tolerability of Bacillus Calmette–Guérin immunotherapy (2026)

Scandinavian Journal of Urology

Nummi, Antti; Nurminen, Pertti; Kesti, Olli; Högerman, Mikael; Ettala, Otto; Boström, Peter J.; Kaipia, Antti; Sairanen, Jukka; Järvinen, Riikka

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Can Radiomics Based Models Survive Across MRI Scanners? (2026)

Lecture Notes in Networks and Systems

Chaudhary, Jatin; Jambor, Ivan; Aronen, Hannu; Ettala, Otto; Saunavaara, Jani; Boström, Peter; Heikkonen, Jukka; Kanth, Rajeev; Merisaari, Harri

(A4 Vertaisarvioitu artikkeli konferenssijulkaisussa)

Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer (2026)

Scandinavian Journal of Urology

Heiskanen, Elja; Kalinen, Sofia; Chu, Rui Jian; Högerman, Mikael; Lamminen, Tarja; Taimen, Pekka; Jambor, Ivan; Aronen, Hannu; Merisaari, Harri; Sainio, Teija; Hakanen, Antti; Ettala, Otto; Laitinen, Kirsi; Vasankari, Tommi; Kallonen, Teemu; Boström, Peter J.; Promic study group

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Evaluating Tumor Quantification in Place of Proportions in Prostate Cancer: Principles of the ProQuant Group (2026)

European Urology

Vickers, Andrew J.; Fine, Samson; on behalf of the ProQuant Group

(B1 Vertaisarvioimaton kirjoitus tieteellisessä lehdessä )

Healthcare Resource Use and Costs of Localized Prostate Cancer Patients in Finland (2025)

Clinical Genitourinary Cancer

Murtola, Teemu J.; Hakkarainen, Tuukka; Lahelma, Mari; Pennanen, Paula; Leskelä, Riikka-Leena; Pietilä, Mika; Hervonen, Petteri; Kääriäinen, Okko-Sakari; Minn, Heikki; Nykopp, Timo K.; Ronkainen, Hanna; Ettala, Otto; Rannikko, Antti

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Long‐Term Risk of Clinically Significant Prostate Cancer in Biopsy‐Negative Patients With Baseline Biparametric Prostate MRI (2025)

Journal of Magnetic Resonance Imaging

Parhiala, Laura; Knaapila, Juha; Jambor, Ivan; Verho, Janne; Syvänen, Kari; Aronen, Hannu; Boström, Peter; Ettala, Otto

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Cross-cultural adaptation and psychometric validation of the Finnish version of the Expanded Prostate Cancer Index Composite-26 for patients with localised prostate cancer (2025)

Scandinavian Journal of Urology

Ettala, Otto; Bergroth, Robin; Riikonen, Jarno; Boström, Peter; Koskimäki, Juha; Kuisma, Jani; Rannikko, Antti; Vaarala, Markku; Sanda, Martin G; Santti, Henrikki

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Otto

Ettala

Contact

Links

Publications

Sort by:

Feasibility and repeatability of DWI-derived diffusion heterogeneity for discriminating clinically significant prostate cancer (2027)

Effect of neoadjuvant androgen deprivation therapy on prostate and tumor morphology prior to MRI-guided transurethral ultrasound ablation of prostate cancer (2026)

Comparison of [18F]DCFPyL and [18F]FAPI-74 PET/CT imaging in metastatic prostate cancer (2026)

Impact of asymptomatic bacteriuria on the outcomes and tolerability of Bacillus Calmette–Guérin immunotherapy (2026)

Can Radiomics Based Models Survive Across MRI Scanners? (2026)

Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer (2026)

Evaluating Tumor Quantification in Place of Proportions in Prostate Cancer: Principles of the ProQuant Group (2026)

Healthcare Resource Use and Costs of Localized Prostate Cancer Patients in Finland (2025)

Long‐Term Risk of Clinically Significant Prostate Cancer in Biopsy‐Negative Patients With Baseline Biparametric Prostate MRI (2025)

Cross-cultural adaptation and psychometric validation of the Finnish version of the Expanded Prostate Cancer Index Composite-26 for patients with localised prostate cancer (2025)